Anavex is a pharmaceutical company engaged in the development of drug candidates.
Quote | Anavex Life Sciences Corp. (NASDAQ:AVXL)
Last: | $3.39 |
---|---|
Change Percent: | 0.88% |
Open: | $3.38 |
Close: | $3.39 |
High: | $3.465 |
Low: | $3.25 |
Volume: | 1,248,187 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | Anavex Life Sciences Corp. (NASDAQ:AVXL)
NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Anavex Life Sciences Corporation (NASDAQ: AVXL)? Did you purchase your shares between February 1, 2022 and January 1, 2024, inclusive? Did you lose money in your in...
Do you, or did you, own shares of Anavex Life Sciences Corporation (NASDAQ:AVXL)? Did you purchase your shares between February 1, 2022 and January 1, 2024, inclusive? Did you lose money in your investment in Anavex Life Sciences Corporation? Do you want to discuss your rights? ...
Message Board Posts | Anavex Life Sciences Corp. (NASDAQ:AVXL)
Subject | By | Source | When |
---|---|---|---|
Only if as an investor in a public | Investor2014 | investorshub | 04/25/2024 5:57:43 PM |
Do we know for certain yet what the | ignatiusrielly35 | investorshub | 04/25/2024 5:24:38 PM |
Different diseases with different disease pathways. Not an | Steady_T | investorshub | 04/25/2024 5:10:59 PM |
It was and is lying to state all | Investor2014 | investorshub | 04/25/2024 5:07:35 PM |
Oh, you know it will? When? | crescentmotor | investorshub | 04/25/2024 5:01:29 PM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
LOS ANGELES, April 23, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class...
LOS ANGELES, April 16, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class...
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceu...